EDN3
protein-codingendothelin 3, the group of Endothelins
Gene summary
The protein encoded by this gene is a member of the endothelin family. Endothelins are endothelium-derived vasoactive peptides involved in a variety of biological functions. The active form of this protein is a 21 amino acid peptide processed from the precursor protein. The active peptide is a ligand for endothelin receptor type B (EDNRB). The interaction of this endothelin with EDNRB is essential for development of neural crest-derived cell lineages, such as melanocytes and enteric neurons. Mutations in this gene and EDNRB have been associated with Hirschsprung disease (HSCR) and Waardenburg syndrome (WS), which are congenital disorders involving neural crest-derived cells. Altered expression of this gene is implicated in tumorigenesis. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Oct 2014]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~25.5 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0013201
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: Unknown
Disease ID:MONDO:0013384
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0013201
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0013201
Submitter: ClinGen
The EDN3 gene has been associated with autosomal recessive Waardenburg syndrome using the ClinGen Clinical Validity Framework as of 12/8/2017. This association was made using case-level data only. At least 7 variants (missense and frameshift) have been reported in humans. EDN3 was first associated with this disease in humans as early as 1996 (Edery et al.). Association is seen in at least 8 probands in 8 publications (8630502, 19764030, 22876130, 20583152, 30394532, 33713422, 8630503, 12189494). Variants in this gene segregated with disease in one additional family member. This gene-disease association is supported by two mouse models with homozygous missense EDN3 variants, which display white spotting, aganglionic megacolon, and early death. In summary, there is moderate evidence to support this gene-disease association. While more evidence is needed to establish this association definitively, no convincing contradictory evidence has emerged. This gene-disease pair was originally evaluated by the ClinGen Hearing Loss GCEP on 5/8/2018. It was reevaluated on 5/17/2023. As a result of this reevaluation, the classification did not change. However additional genetic evidence has been included and scoring adjusted to the current Gene Clinical Validity SOP Version 9. The new genetic evidence included these publications (PMID: 20583152, 30394532, 33713422, 8630503, 12189494) and an additional proband was identified in Moghadam et al 2020 and scored 1.1 (http://repozytorium.ur.edu.pl/handle/item/5791). As the paper did not have a pubmed ID the relevant information was entered under non-scorable evidence. Therefore, the actual score for genetic evidence is 3.9 (including the score from Moghadam et al 2020 (1.1) and score for consanguineous probands (-0.4)). The final total points are 8.4 (MODERATE).
Inheritance Pattern: AD
Disease ID:MONDO:0013384
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0013201
Submitter: ClinGen
The EDN3 gene has been associated with autosomal dominant Waardenburg syndrome using the ClinGen Clinical Validity Framework as of 12/8/2017. This association was made using case-level data only. At least 1 frameshift variant has been reported in humans. EDN3 was first associated with this disease in humans as early as 1999 (Svensson et al.). This gene-disease association is supported by relevant experimental evidence including expression data and a mouse model with white belly spots carrying a heterozygous p.Arg96His variant. In summary, there is limited evidence to support this gene-disease association. Although more evidence is needed to support a causal role, no convincing evidence has emerged that contradicts the gene-disease association.
Inheritance Pattern: AD
Disease ID:MONDO:0013201
Submitter: G2P
Inheritance Pattern: SD
Disease ID:MONDO:0013201
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0019518
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0019518
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0013201
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0013201
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0019518
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Audiologic/Otolaryngologic; Dermatologic; Gastrointestinal; Neurologic; Ophthalmologic; Pulmonary
Intervention: Audiologic/Otolaryngologic; Gastrointestinal; Neurologic; Pulmonary
Rationale: Early recognition and treatment of hearing impairment may improve outcomes, including speech and language development; In conditions that may involve Hirschsprung disease, recognition of potential GI anomalies (eg, aganglionosis) may allow prompt recognition and treatment; In Central hypoventilation syndrome, congenital, early recognition and interventions to support ventilation (as well as avoidance of exacerbating factors) can reduce morbidity and mortality
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to EDN3 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_207034.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 3 | 25 | 1 | 29 | ||
| missense | 3 | 2 | 86 | 4 | 1 | 96 |
| nonsense | 1 | 1 | ||||
| start loss | 0 | |||||
| frameshift | 1 | 5 | 3 | 1 | 10 | |
| splice donor/acceptor (+/-2bp) | 1 | 1 | ||||
| Total | 5 | 7 | 93 | 30 | 2 | 137 |
Highest pathogenic variant AF is 0.000003422529
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_996917.1 | 5 | MANE Select | |
| Ensembl | ENSP00000337128.2 | 5 | MANE Select | |
| RefSeq | NP_001289384.1 | 5 | Standard | |
| RefSeq | NP_001289385.1 | 4 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| edn3b | Danio rerio | Structure: melanocyte Quality: decreased pigmentation abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Signaling by GPCR
- Signal Transduction
- GPCR signaling-G alpha q
- GPCR signaling-cholera toxin
- GPCR signaling-pertussis toxin
Biological Process
- neural crest cell migration
- positive regulation of leukocyte chemotaxis
- regulation of systemic arterial blood pressure by endothelin
- cellular calcium ion homeostasis
- signal transduction
Molecular Function
- signaling receptor binding
- hormone activity
- endothelin B receptor binding
Cellular Component
- extracellular region
- extracellular space
- cell
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000337938
- Coding exons
- 5
- Length
- 25566
- Individuals with no LoFs
- 125666
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 5
- Defined
- 125671
- p
- 0.0000199
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.939 | 168 | 137 | 1.23 | 0.00000874 | 1519 |
| Missense (PolyPhen) | 33 | 34.757 | 0.94946 | 366 | ||
| Synonymous | 0.118 | 57 | 58.1 | 0.980 | 0.00000390 | 492 |
| Loss of Function | 1.65 | 4 | 9.50 | 0.421 | 4.99e-7 | 107 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00012 | 0.00012 | rare |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0.00010 | 0.000099 | rare |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0.000046 | 0.000046 | rare |
| European (Non-Finnish) | 0.0000090 | 0.0000088 | rare |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Endothelins are endothelium-derived vasoconstrictor peptides.;
- Disease
- DISEASE: Congenital central hypoventilation syndrome (CCHS) [MIM:209880]: Rare disorder characterized by abnormal control of respiration in the absence of neuromuscular or lung disease, or an identifiable brain stem lesion. A deficiency in autonomic control of respiration results in inadequate or negligible ventilatory and arousal responses to hypercapnia and hypoxemia. {ECO:0000269|PubMed:8696331}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Waardenburg syndrome 4B (WS4B) [MIM:613265]: A disorder characterized by the association of Waardenburg features (depigmentation and deafness) with the absence of enteric ganglia in the distal part of the intestine (Hirschsprung disease). {ECO:0000269|PubMed:11303518, ECO:0000269|PubMed:12189494, ECO:0000269|PubMed:8630503}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.370
Intolerance Scores
- LoFtool
- 0.0739
- RVIS EVS
- -0.36
- RVIS percentile EVS
- 28.93
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.0610
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |